603811.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 10:00):

Stats
Dzisiejszy wolumen	4.45M
Średni wolumen	4.77M
Kapitalizacja rynkowa	2.79B
EPS	CNY0.218 ( 2023-06-30 )
Następna data zysków	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	17.75
ATR14	CNY0.00800 (0.09%)

Wolumen Korelacja

Długi: 0.12 (neutral)

Krótki: -0.65 (moderate negative)

Signal:(45.472) Neutral

Zhejiang Cheng Yi Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhejiang Cheng Yi Korelacja - Waluta/Towar

-0.42
( neutral )

0.22
( neutral )

0.00
( neutral )

0.52
( weak )

0.75
( moderate )

Zhejiang Cheng Yi Finanse

Annual	2023
Przychody:	CNY671.63M
Zysk brutto:	CNY431.03M (64.18 %)
EPS:	CNY0.500

FY	2023
Przychody:	CNY671.63M
Zysk brutto:	CNY431.03M (64.18 %)
EPS:	CNY0.500

FY	2022
Przychody:	CNY654.97M
Zysk brutto:	CNY448.16M (68.42 %)
EPS:	CNY0.490

FY	2021
Przychody:	CNY693.96M
Zysk brutto:	CNY501.36M (72.25 %)
EPS:	CNY0.730

Financial Reports:

No articles found.

Zhejiang Cheng Yi

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs and capsules/tablets in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Wenzhou, China.